NEXTBio Capital Management LP

AUSTIN, TX · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 13, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$234.4M2026 Q3
Positions25
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.67.6%

NEXTBio Capital Management LP reported 25 positions worth $234.4M as of September 30, 2026 (13F filed November 13, 2026). Largest holding: PTGX (13.2%).

10 / 25 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 PTGXProtagonist Therapeutics$30.9M13.19%219,333——-11.4%
▸ 2 STTKShattuck Labs$25.4M10.85%3,727,348——-14.1%
▸ 3 CMPSCOMPASS Pathways$22.1M9.43%1,775,759——-33.5%
▸ 4 RYTMRhythm Pharmaceuticals$12.5M5.35%131,758——+12.9%
▸ 5 VORVor Biopharma$11.8M5.05%620,931——-0.6%
▸ 6 PHVSPharvaris N.V.$11.8M5.04%372,552——+2.3%
▸ 7 XENEXenon Pharmaceuticals$11.5M4.92%310,225——+5.6%
▸ 8 ZBIOZenas BioPharma$11.5M4.91%426,736———
▸ 9 PVLAPalvella Therapeutics$11.1M4.73%80,409——+4.8%
▸ 10 GPCRStructure Therapeutics$9.8M4.17%312,496——-36.0%

Pro Feature

The remaining 15 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does NEXTBio Capital Management LP hold as of Q3 2026?

NEXTBio Capital Management LP reported 25 positions worth $234.4M in its Q3 2026 13F filing. Largest positions: PTGX (13.2%), STTK (10.8%), CMPS (9.4%), RYTM (5.4%) and VOR (5.1%).

What did NEXTBio Capital Management LP buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did NEXTBio Capital Management LP sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.